Phenytoin normalizes exaggerated fear behavior in p-chlorophenylalanine (PCPA)-treated rats

Epilepsy and Behavior

Volumn 9, Issue 4, 2006, Pages 557-563

  Hughes, Cathryn R ^a   Keele, N Bradley ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

Amygdala; Anticonvulsant; Behavior; Fear potentiated startle; Hyperexcitability; Phenytoin; Rat; Serotonin

Indexed keywords

FENCLONINE; PHENYTOIN; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEAR; MALE; NERVE CELL EXCITABILITY; NONHUMAN; RAT; SEROTONIN RELEASE; STARTLE EPILEPSY;

AMYGDALA; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; FEAR; FENCLONINE; MALE; PHENYTOIN; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS; STARTLE REACTION;

EID: 33751328039     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.09.002     Document Type: Article

References (40)

1. LaBar K.S., Gatenby J.C., Gore J.C., LeDoux J.E., and Phelps E.A. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 20 (1998) 937-945
2. Adolphs R., Tranel D., and Damasio A.R. The human amygdala in social judgment. Nature 393 (1998) 470-474
3. Bechara A., Tranel D., Damasio H., Adolphs R., Rockland C., and Damasio A.R. Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science 269 (1995) 1115-1118
4. Davidson R.J., Abercrombie H., Nitschke J.B., and Putnam K. Regional brain function, emotion and disorders of emotion. Curr Opin Neurobiol 9 (1999) 228-234
5. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 23 (2000) 155-184
6. Gloor P. Role of the amygdala in temporal lobe epilepsy. In: Aggleton J. (Ed). The amygdala: neurobiological aspects of emotion, memory and mental dysfunction (1992), Wiley-Liss, New York 505-538
7. Keele N.B. The role of serotonin in impulsive and aggressive behaviors associated with epilepsy-like neuronal hyperexcitability in the amygdala. Epilepsy Behav 7 (2005) 325-335
8. Rosen J.B., and Schulkin J. From normal fear to pathological anxiety. Psychol Rev 105 (1998) 325-350
9. Barratt E.S., Stanford M.S., Felthous A.R., and Kent T.A. The effects of phenytoin on impulsive and premeditated aggression: a controlled study. J Clin Psychopharmacol 17 (1997) 341-349
10. Stanford M.S., Helfritz L.E., Conklin S.M., et al. A comparison of anticonvulsants in the treatment of impulsive aggression. Exp Clin Psychopharmacol 13 (2005) 72-77
11. Adamec R., and Young B. Neuroplasticity in specific limbic system circuits may mediate specific kindling induced changes in animal affect: implications for understanding anxiety associated with epilepsy. Neurosci Biobehav Rev 24 (2000) 705-723
12. Keele N.B. Phenytoin inhibits isolation-induced aggression specifically in rats with low serotonin. Neuroreport 12 (2001) 1107-1112
13. Rumpel S., LeDoux J., Zador A., and Malinow R. Postsynaptic receptor trafficking underlying a form of associative learning. Science 308 (2005) 83-88
14. Rogan M.T., Staubli U.V., and LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390 (1997) 604-607
15. McKernan M.G., and Shinnick-Gallagher P. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390 (1997) 607-611
16. Rainnie D.G. Serotonergic modulation of neurotransmission in the rat basolateral amygdala. J Neurophysiol 82 (1999) 69-85
17. Stutzmann G.E., and LeDoux J.E. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci 19 11 (1999) RC8
18. Burghardt N.S., Sullivan G.M., McEwen B.S., Gorman J.M., and LeDoux J.E. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55 (2004) 1171-1178
19. Ramboz S., Oosting R., Amara D.A., et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95 (1998) 14476-14481
20. Saudou F., Amara D.A., Dierich A., et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265 (1994) 1875-1878
21. Valzelli L., Bernasconi S., and Dalessandro M. Time-courses of p-CPA-induced depletion of brain serotonin and muricidal aggression in the rat. Pharmacol Res Commun 15 (1983) 387-395
22. Heidbreder C.A., Weiss I.C., Domeney A.M., et al. Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome. Neuroscience 100 (2000) 749-768
23. Keele N.B., and Randall D.R. Altered modulation of excitatory neurotransmission in the amygdala by serotonin in an animal model of impulsive-aggression. Ann NY Acad Sci 985 (2003) 528-532
24. Risbrough V.B., Brodkin J.D., and Geyer M.A. GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice. Neuropsychopharmacology 28 (2003) 654-663
25. Joordens R.J., Hijzen T.H., Peeters B.W., and Olivier B. Fear-potentiated startle response is remarkably similar in two laboratories. Psychopharmacology (Berl) 126 (1996) 104-109
26. Joordens R.J., Hijzen T.H., and Olivier B. The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response. Psychopharmacology (Berl) 139 (1998) 383-390
27. Groenink L., Joordens R.J., Hijzen T.H., Dirks A., and Olivier B. Infusion of flesinoxan into the amygdala blocks the fear-potentiated startle. Neuroreport 11 (2000) 2285-2288
28. Zangrossi Jr. H., Viana M.B., and Graeff F.G. Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. Eur J Pharmacol 369 (1999) 267-270
29. Inoue T., Li X.B., Abekawa T., et al. Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur J Pharmacol 497 (2004) 311-316
30. Bhatnagar S., Sun L.M., Raber J., Maren S., Julius D., and Dallman M.F. Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav 81 (2004) 545-555
31. Hen R. Mean genes. Neuron 16 (1996) 1721
32. Gross C., Santarelli L., Brunner D., Zhuang X., and Hen R. Altered fear circuits in 5-HT(1A) receptor KO mice. Biol Psychiatry 48 (2000) 1157-1163
33. Bouwknecht J.A., Hijzen T.H., van der Gugten J., Maes R.A., Hen R., and Olivier B. Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice. Biol Psychiatry 49 (2001) 557-568
34. Rogawski M.A., and Loscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10 (2004) 685-692
35. McNamara J.O., Rigsbee L.C., Butler L.S., and Shin C. Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann Neurol 26 (1989) 675-678
36. Douglas Bremner J., Mletzko T., et al. Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study. J Clin Psychiatry 65 (2004) 1559-1564
37. Rosen J.B., Hamerman E., Sitcoske M., Glowa J.R., and Schulkin J. Hyperexcitability: exaggerated fear-potentiated startle produced by partial amygdala kindling. Behav Neurosci 110 (1996) 43-50
38. Adamec R.E., and Stark-Adamec C. Partial kindling and emotional bias in the cat: lasting aftereffects of partial kindling of the ventral hippocampus: I. Behavioral changes. Behav Neural Biol 38 (1983) 205-222
39. Adamec R.E., and Morgan H.D. The effect of kindling of different nuclei in the left and right amygdala on anxiety in the rat. Physiol Behav 55 (1994) 1-12
40. Nieminen S.A., Sirvio J., Teittinen K., Pitkanen A., Airaksinen M.M., and Riekkinen P. Amygdala kindling increased fear-response, but did not impair spatial memory in rats. Physiol Behav 51 (1992) 845-849